Written by Mr Michael Kenihan.
I recently attended the American College of Sports medicine meeting in Denver Colorado.
Eminent scientist, Thomas Best also spoke about the emerging research in stem cell therapy.
He spoke in detail about where the world of stem cell research is at in the current literature and the role that stem cells will play in regenerative medicine. To summarise he detailed stem cells the good, the bad and the ugly:
The good: there is strong evidence that stem cell treatment is entirely safe to use and growing evidence that stem cells have a disease modifying effect on osteoarthritis.
The bad: there is only poor quality studies in the literature.
MSCC and Magellan Stem Cells are hoping to add to that body of evidence when we commence our Allogeneic trial in the near future. That is in addition to the more recent trial we have conducted and the preliminary results that detail the efficacy of stem cells in reducing pain and improving function along with, in some cases, regeneration of what appears to be type one cartilage.
The ugly: the advent of unscrupulous operators who are promoting “stem cell tourism” are causing headaches for regulators and in some instances severe adverse consequences for the un-suspecting and desperate public.
I want to advise you that MSCC and Magellan Stem Cells are working at the forefront of the emerging stem cell industry and will continue to support everything we do with evidence based treatments. In 2016 Melbourne Stem Cell Centre became concerned around the need for stem cell treatments to be based on good science. If you would like to read more about this please click here